Testosterone Topical Solution is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone. It is applied via an armpit (underarm) applicator.
Other forms of testosterone replacement therapy include oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections and topical gels applied by the hands.
Acrux licenced Testosterone Topical Solution to Dash Pharmaceuticals LLC for sale in the United States. It was launched in 2021.
